The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hmm, starting to push the definition now. Whilst I take the exercising of warrants as a good sign, I sincerely hope they are not seeking to use the break to try and bury mediocre results. Doing what they have said they will do would certainly help investor confidence, which for many is pretty fragile where this one is concerned. Tomorrow the last opportunity to allow it proper momentum if the results are good.
Really terrific - well done to the team. This still feels undervalued but I’d rather have contract wins in the bank and a market that’s yet to catch up than an outlandish share price without the contracts to justify it.
‘What happened to the huge price rise everyone predicted after Dubai meeting ????’
Starship, when you say ‘everyone’, I think you’ll find it was actually pretty much ‘someone’ and a couple of devoted followers. Think about it, why would there be a huge share price rise after a presentation which was only allowed to contain information already publicly available? It was a silly assertion to make. With some posters on here, I would urge you to take note of the times they appear, create a big noise, and then disappear. And always think for yourself.
I hope we’ll see good news on assay results in the next few days - now that actually has the potential to prompt a rise.
Best of luck.
completelynew - with respect, your short-term outlook is not well suited to shares full stop, let alone AIM shares. It sounds as though you already sold at a loss. Good luck with wherever else you decided to invest. Over 5-10 years, this is going to do just great.
Ah, that could be a very good shout deepjoy.
Absolutely. Remember that this is also the time of year a lot of PIs will reassess their holdings and - some notable peaks and troughs aside - this has essentially been flat in 2021. There is a relatively recent brand of investor who appear to believe that unless you get a thousand per cent return within the time it takes to boil an egg then something is a dud. I suspect there’s some of that going on as the short-termers (12 months or less) believe they can get better immediate returns elsewhere.
Just taken another 160k shares at 3.14 - couldn’t resist. Almost my entire GFIN holding is within my SIPP so the enforced luxury of taking at least a 5-10yr view here (though actually I suspect it will be acquired within that timeframe). Wouldn’t be at all surprised to see this back at 3.70 - 4.00 within a matter of weeks. Good luck all.
Looks like the gold assay results is either tomorrow or, more likely, next week. I’d hope it’s no later than next week otherwise any momentum it may create will be interrupted by the markets closing for periods over Christmas.
I’ll ask her tonight between her Maths homework and her supper. Don’t worry, if she’s totally wrong she can just have another guess in a few months! I can feel a study coming on here. Deutsche analysts v Class 7F on a range of shares.
Licker, I totally agree. But it begs the question of why their analysts get paid anything at all, let alone what they do get paid. I might get my 12 year old daughter to apply for a job there and she can get paid handsomely to have a guess.
Just catching up with Friday’s note from Deutsche Bank. Upgraded their Brent price forecast for 2022 by almost 20% and adjusted their target price for BP to 404p from 320p when the share price was 340p. Gosh, what skilled, precise and technically superior individuals these analysts are.
In my job, I would be asked some serious questions as to why my initial forecasts and targets were so wide of the mark!
Hi Burleigh, I think the other consideration is what it is that ORCP are able to actually sell on. As I understand it they have a 30 year mining lease on Thar Block VI - is this even something that can be sold? Naheed Memon’s intimation that they could sell their interest (remember it’s a minority stake) suggests that there is a significant commercial value to be sold on, but I’m not sure it’s entirely straightforward.
Spot on KSH. I would add a fourth category, which is crazy rampers who mis-timed it and by virtue of the fact that they got trapped for (horror of horrors) several weeks, now believe themselves to be ‘long-term’ shareholders!
What strange behaviour... To copy a Twitter post and then paste it on the forum that you know the original author also posts on. It almost seems as though there’s probably a simpler, far less convoluted explanation. Good luck to you Casper ;)
Thanks Bluebelly. So just to check my understanding, if I held TILS, it’s TLSA shares these will be converted to (albeit 2 for 1)? What’s the relevance of Accustem? I can see it’s a subsidiary but these are not what TILS are being converted to?
I don’t wish to exacerbate any pain anybody is feeling but I am unsure whether my TILS shares are being converted (I still don’t have them) into NASDAQ listed TLSA shares or info Accustem shares. The only information I received prior to the delisting stated ‘You’ll receive 1 share in the new Bermuda incorporated Tiziana Life Sciences in place of every 2 shares held’ so I have always assumed it would be TLSA (Tiziana Life Sciences). Can anybody help clarify?